## Overview Magnesium supplementation has achieved a **Level B "probably effective"** recommendation from major neurological societies (including the American Academy of Neurology) for migraine prevention. This represents one of the strongest evidence bases for any natural intervention in headache medicine. **Core Insight**: Magnesium addresses migraine through multiple mechanisms—not just symptom suppression—making it a disease-modifying intervention rather than merely palliative. ## Evidence Summary ### Efficacy Data | Metric | Finding | Source | |--------|---------|--------| | Attack frequency reduction | 33-42% | RCT meta-analyses | | Evidence level | Level B "probably effective" | AAN/AHS guidelines | | Optimal daily dose | 400-600 mg | Clinical trials | | Time to effect | 3-4 months | Typical trial duration | ### Best Responders Strongest evidence supports efficacy in: 1. **Migraine with aura** - May reduce cortical spreading depression 2. **Menstrual-related migraine** - Addresses hormonal magnesium fluctuations 3. **Documented magnesium deficiency** - Correcting underlying insufficiency 4. **Those with inadequate dietary intake** - ~50% of population ### Form Selection for Migraine | Form | Recommendation | Notes | |------|----------------|-------| | Glycinate | Preferred | High absorption, calming co-benefits | | Citrate | Good alternative | Well-absorbed, may help with constipation | | Oxide | Not recommended | Poor absorption (~4%) despite common use | | Taurate | Consider | Cardiovascular co-benefits | ## Dosing Protocol **Standard Preventive Regimen**: - **Starting dose**: 200-400 mg daily - **Target dose**: 400-600 mg daily - **Timing**: Divided doses (morning and evening) improve tolerance - **Duration**: Minimum 3 months trial before assessing efficacy **Titration Strategy**: ``` Week 1-2: 200 mg daily Week 3-4: 400 mg daily (divided) Week 5+: 600 mg daily if tolerated and needed ``` ## Mechanism of Action Magnesium prevents migraine through multiple pathways: 1. **NMDA receptor antagonism** - Reduces cortical excitability 2. **Vascular regulation** - Prevents vasospasm 3. **Serotonin receptor effects** - Modulates pain signaling 4. **Substance P inhibition** - Reduces neurogenic inflammation 5. **Cortical spreading depression** - May reduce aura propagation > See [[Magnesium Mechanisms of Action]] for detailed neurological mechanisms. ## Cross-Domain Applications ### Pattern Recognition: Multi-Mechanism Interventions Migraine prevention illustrates the value of addressing root causes through multiple pathways rather than single-target symptomatic treatment. This applies to: - **Chronic disease management** - Lifestyle interventions vs single medications - **Systems thinking** - Multiple leverage points more effective than single fixes - **Problem-solving** - Root cause analysis over symptom treatment ### Threshold and Trigger Model Migraine operates on a threshold model—attacks occur when cumulative triggers exceed individual threshold. Magnesium raises the threshold, making the system more resilient. This model applies to: - **Stress management** - Building resilience vs eliminating stressors - **System reliability** - Buffer capacity in engineering - **Personal energy** - Maintaining reserves before burnout ### Evidence-Based Decision Making The Level B recommendation demonstrates how evidence accumulates: - Multiple RCTs showing consistent direction - Plausible biological mechanism - Acceptable safety profile - Cost-effectiveness consideration ## Clinical Considerations ### Who Should Consider - Migraine frequency ≥4 days/month - Contraindications to standard preventives (beta-blockers, antidepressants) - Preference for natural approaches - Suspected magnesium deficiency - Menstrual-pattern migraines - Migraine with aura ### Who Should Avoid/Use Caution - Kidney disease (impaired excretion) - Taking medications that interact (certain antibiotics, bisphosphonates) - Severe diarrhea history (citrate form) ### Monitoring - **Efficacy**: Headache diary tracking frequency, intensity, duration - **Tolerability**: GI symptoms, especially first 2 weeks - **Long-term**: Periodic renal function if extended use ## Critical Analysis **Strengths**: - Well-established safety profile - Low cost compared to pharmaceuticals - Multiple mechanisms of action - May address underlying deficiency **Limitations**: - Most trials don't assess baseline magnesium status - Variable forms and doses across studies - Significant placebo effects in migraine trials - 3-4 month trial needed to assess efficacy **Open Questions**: - Optimal magnesium form for migraine specifically - Role of RBC magnesium testing in predicting response - Combination protocols with other preventives ## Future Research Directions - [ ] Research RBC magnesium as response predictor - [ ] Compare glycinate vs citrate for migraine specifically - [ ] Investigate combination with riboflavin (B2) and CoQ10 ## Related Concepts - [[Magnesium Forms Comparison]] - Selecting optimal form - [[Magnesium Deficiency Recognition]] - Identifying candidates - [[Magnesium Mechanisms of Action]] - Neurological pathways - [[Supplement Timing Strategies]] - Optimizing dosing schedule ## References **Primary Source**: [[3 Archives/Magnesium and Specific Conditions:3]] (evidence summary) **Key Citations**: - American Migraine Foundation: [Magnesium](https://americanmigrainefoundation.org/resource-library/magnesium/) - AAN Guidelines: [Migraine Prevention](https://www.neurology.org/doi/10.1212/WNL.0b013e3182535d20) ## Personal Notes & Applications **Household relevance**: - Note any family history of migraine - Consider for family members with frequent headaches - Track correlation with menstrual cycle if applicable **Implementation checklist**: - [ ] Start with glycinate form - [ ] Begin headache diary before starting - [ ] Titrate slowly over 4 weeks - [ ] Assess at 3-month mark **Last updated**: 2026-01-04